UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME
Anticoagulant therapy is widely used in all forms of acute coronary syndrome (ACS) to inhibit the formation of thrombin and/or to inhibit its activity to reduce the risk of thrombotic events (both in primary percutaneous coronary intervention and in the absence of revascularization). Of the entire r...
Main Authors: | O. V. Krikunova, R. I. Stryuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2018-03-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/1608 |
Similar Items
-
THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01) -
Choosing between Enoxaparin and Fondaparinux for the management of patients with acute coronary syndrome: A systematic review and meta-analysis
by: Pravesh Kumar Bundhun, et al.
Published: (2017-05-01) -
FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
by: G. V. Mardaryan, et al.
Published: (2015-09-01) -
Effect of Subcutaneous Enoxaparin Injection Duration on Site-Pain Intensity in Acute Coronary Syndrome Patients Hospitalized in CCU Afshar Hospital, Yazd, 2011
by: Z Najari, et al.
Published: (2012-10-01) -
Enoxaparin in cardiovascular disease: how to improve effectiveness and safety?
by: I. S. Yavelov
Published: (2011-12-01)